Synta66 是一种钙池操纵钙离子通道 Orai 抑制剂，用于神经系统疾病的研究。

Synta66 is a store-operated calcium entry channel Orai inhibitor, and used for the research of neurological disease.

Synta66 is an inhibitor of Orai, which forms the pore of the CRAC channel.Synta66 (10 μM) suppresses human platelet activation in plasma and whole-blood thrombus formation. Synta66 (10 μM) inhibits LAD2 human mast cell line.

835904-51-3

C20H17FN2O3

352.36

DMSO:60 mg/mL (170.28 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years